Monday, December 31, 2007

New year price hikes, as if on cue

ANYONE with an air conditioner should cherish the relief today because the cost of running it is going to rise substantially in the new year.

Like the fireworks at midnight, we could set our watches by the price rises that herald the new year, and along with electricity, the cost of public transport, toll booths and health care will rise.

Energy bills will be the most significant of the new year price rises for Victorian consumers.

On January 1, Victoria's three biggest energy retailers — Origin Energy, AGL and TRUenergy — will charge up to 17% more for power, after the drought, increased demand and renewable energy targets pushed the cost of generating electricity to record highs.

An average household paying $945 annually for its power bill is likely to pay $1106 for consuming 6500 kilowatt hours of peak and off-peak electricity. A larger family could face a rise of about $220 annually.

Riding trams, trains and buses will be more expensive in January, with the the cost of public transport in Melbourne rising by about 20 cents per trip, with a zone 1, two-hour full fare going from $3.30 to $3.50, and a zone 1-and-2, two-hour ticket rising from $5.30 to $5.50.

And you will not escape the price rises by taking the car, with Citylink passes set to rise by 4.5%, with an e-tag day pass going up to $5.97 and a 24-hour pass rising to $11.45.

Health too, will get more expensive.

The amount you have to spend to be eligible for the Medicare Safety Net — under which the Government picks up 80% of medical costs after you've spent a certain amount in a year — will rise by $9.80 to $529.30 for concession card holders and $19.70 to $1058.70 for general patients.

It will also be harder to qualify for the Pharmaceutical Benefits Scheme safety net. The threshold for general patients will rise $82.80 to $1141.80 and for concession card holders it will go up $15.60 to $290.

The amount patients will have to contribute to the cost of subsidised medicines will go up 60 cents to $31.30 for general patients and 10 cents to $5 for concession card holders.

But it is not all bad news.

Several new drugs will attract subsidies from tomorrow, including Champix for those quitting smoking and Alimta for the asbestos-related cancer mesothelioma.

And it will be easier to get eye treatment, with optometrists given the right to prescribe certain subsidised medications for the first time.


Source


Friday, December 28, 2007

State funeral for Bernie Banton

Bernie Banton, the public face of the campaign against asbestos company James Hardie, has died, but his efforts have been hailed as a decades-long legacy for asbestos disease sufferers.

Mr Banton, 61, died at his Sydney home about 1am (AEDT) on Tuesday with his family by his side.

His wife Karen, brother Bruce, sister Grace and five children have accepted the NSW government's offer of a state funeral.

Mr Banton was diagnosed in August with peritoneal mesothelioma, an abdominal cancer caused by his exposure to asbestos when he worked for a subsidiary of James Hardie from 1968 to 1974.

He had already been suffering for years from asbestosis, a lung disease also caused by exposure to asbestos.

Despite this, he led the campaign to force James Hardie to establish a fund that would provide adequate compensation for all its employees suffering from diseases caused by their exposure to asbestos at its factories.

He was, NSW Premier Morris Iemma said, "a truly great Australian, a man who fought for others at a time when he should have been worrying about his own health".

"In November 2006, on the day we signed the final agreement to secure compensation for Hardie victims (workers in James Hardie factories who contracted diseases caused by asbestos), Bernie knew he'd achieved something special.

"That deal was worth $1.5 billion over the next 40 years for those who suffered and continue to suffer this dreadful disease.

"It would not have been possible without Bernie Banton."

Prime Minister-elect Kevin Rudd said he was "a fighter" who was "a symbol, a living symbol of what is right and decent and proper in the workplace relations of this country".

"Australia is going to be poorer for Bernie's passing - our whole nation will be poorer for Bernie's passing," Mr Rudd said.

Mr Banton was diagnosed in 1999 with asbestosis and ARPD (asbestos-related pleural disease), which reduced his lung capacity to 40 per cent.

He began to rely on an oxygen bottle, but he refused to let it slow him down, taking it with him everywhere he went as he campaigned for fair compensation from James Hardie for all its affected workers.

Estimates of future claims continued to rise, and the company was eventually forced in December 2004 to sign Australia's largest ever compensation settlement, worth up to $4.5 billion over 40 years.

In a statement, James Hardie expressed its condolences to the family of Mr Banton, acknowledging his work in raising public awareness of asbestos-related disease.

"The company acknowledges the significant contribution Mr Banton made to raising the awareness of asbestos-related diseases in Australia, and his role in the eventual implementation of the final funding agreement to compensate Australians with asbestos-related personal injury claims," the company said.

NSW parliament rose for a moment's silence and both sides of politics delivered statements praising him.

"Bernie courageously pursued justice for sufferers of asbestos-related diseases and their families, we all owe him a debt of gratitude," NSW Industrial Relations Minister John Della Bosca said.

Former ACTU secretary Greg Combet said Mr Banton had been a fighter for other people and a fighter for justice.

"I hope that people properly appreciate the importance of the settlement that was reached with James Hardie a few years back, because it was a very hard fight and Bernie contributed a lot," Mr Combet said.

"That's how he should be recognised."

Last Thursday, Mr Banton won a confidential payout as compensation for his terminal mesothelioma, including exemplary damages for what his lawyers called James Hardie's "contumelious" disregard for the health of its workers when they knew of the dangers of asbestos.

In 2000, he had been awarded $800,000 compensation for asbestosis.

And last month he succeeded in getting the palliative drug Alimta subsidised by the federal government for mesothelioma sufferers.

His brother Bruce said Mr Banton's funeral would probably be held on Saturday but details were still being discussed.

"One thing we will be asking is for instead of flowers at the service is donations for asbestos research and treatments," he said.

In a further tribute, the Asbestos Diseases Research Institute at Sydney's Concord hospital will also be named the Bernie Banton Centre.

In Melbourne, he was honoured at a commemorative service, part of Asbestos Awareness Week, to remember people who have died from asbestos-related diseases.

Source



Victims of asbestos fight payout 'apartheid'

People suffering from pleural plaques through exposure to asbestos will soon be facing a postcode lottery to determine whether they qualify for compensation.

Pleural plaques are a scarring on the lining of the lungs, an asymptomatic sign of exposure to asbestos that does not of itself lead to more serious asbestos-related conditions. While about 1,800 people die of asbestos-related diseases each year in Britain, a number that is rising, some commentators have labelled plaques sufferers as 'the worried well' and the House of Lords recently ruled that the condition was not worthy of compensation.

'When people say those things, it's because they haven't had to live with it,' says Valerie Pask, a 55-year-old mother of seven from Nottingham who was diagnosed with plaques last year. Asbestos has left its mark on three generations of her family. 'I'll never forget my eldest brother in the final weeks before he died,' she recalls. 'He was unable to say more than a few words because his lungs were so congested.'

Valerie's brother died from mesothelioma, the cancer contracted from breathing in asbestos dust. Her father worked all his life as a lagger, fitting insulation at power stations. He died of heart disease in 1980, at the age of 65, with his death certificate recording that the condition was 'related to asbestosis'. 'My eldest brother, Brian, died at the age of 50 in 1987 and my next eldest brother, Michael, died in 1991,' she says. Three sons worked with their father. Two of them had their lives cut short by mesothelioma and the surviving brother was recently diagnosed with asbestosis. Her brother-in-law and sister-in-law, who worked with them, have both died of asbestos-related conditions, as did an uncle who worked in London.

But the tragedy doesn't end there. Valerie and her three sisters would clean their father's dust-covered overalls when he came back from the power stations, where he eventually became a site manager. 'He'd take his work clothes off in the conservatory and we'd beat them and get as much dust off as we could; otherwise our washing machine would get clogged up,' she recalls. Two of the four women have been diagnosed with plaques, as has one of their daughters.

In October, the Law Lords refused to overrule an appeal court ruling in January 2006 preventing plaques sufferers from claiming damages (in Rothwell v Chemical & Insulating Co). 'Proof of damage is an essential element in a claim in negligence and in my opinion the symptomless plaques are not compensatable,' ruled Lord Hoffmann.

That ruling will affect 'thousands who have faced emotional anguish since their diagnosis', says Adrian Budgen, head of the asbestos unit at law firm Irwin Mitchell. 'Plaques are a consequence of negligent exposure to asbestos. This exposure physically scars victims and is often a precursor to very serious and sometimes fatal disease.' Budgen, who is advising Valerie, adds: 'With a family history like theirs, you're going to be worried. She is a relatively young woman who has to live with this for the rest of her life.'

The Scottish government announced this month that it intended to reverse the Law Lords' ruling by introducing new legislation. 'The effects of asbestos are a terrible legacy of Scotland's industrial past and we should not turn our backs on those who contributed to our nation's wealth,' said Holyrood's Justice Secretary, Kenny MacAskill. 'Pleural plaques in anyone exposed to asbestos mean they have a greatly increased lifetime risk of developing mesothelioma. This will mean that people diagnosed with this condition will have to live with the worry of possible future ill-health for the rest of their lives.'

The Association of British Insurers calls the Scottish approach 'misguided'. Insurers are 'fully committed' to compensating claimants with mesothelioma and other asbestos-related diseases, says the ABI's Stephen Haddrill, but 'introducing legislation to overturn a unanimous Law Lords' ruling could significantly increase costs for Scottish businesses'.

None the less, insurers had been paying out for plaques for 20 years prior to the Rothwell case and payouts have been modest. Since the January 2006 ruling, 'full and final' damages, which settle the case once and for all, have been cut from £12,500-£20,000 to £5,000-£7,000.

There is a recent precedent for ministers in England and Wales stepping in to protect families from the courts when they overruled the House of Lords judgment by the Law Lords in the case of Sylvia Barker in 2006. In that case (The Observer, 5 March 2006), insurers argued that if there was more than one employer, compensation for mesothelioma should be split between them. As some have now gone out of business, this would have meant families missing out on part or all of their compensation. Ministers therefore amended the Compensation Act to protect families.

Campaigners are pessimistic about Westminster following the Scottish lead on plaques cases, even though the construction union Ucatt last week won a government commitment to review the Rothwell decision. 'It's going to look unjust if you have sufferers in Scotland receiving compensation and those south of the border aren't,' says Tony Whitson, chair of the Asbestos Victims Support Groups Forum UK.

Campaigners point to a growing difference between England and Wales on the one hand and Scotland on the other, where the life-extending drug Alimta is more readily available for mesothelioma sufferers and where bereavement payments of up to £30,000 have been made by the courts (such compensation is fixed at £10,000 in England). Now it seems likely plaques sufferers will only get compensation in Scotland.

Valerie says: 'What makes me angry is that if you have a minor scar on your body you can get compensation. Thousands of people receive compensation for stress, but we get nothing. The scarring is inside me.'

She says she suffers nightmares and has been out socialising only four times since she was diagnosed 18 months ago. 'Employers knew the harm asbestos was doing and carried on using it because it was cheap,' she says. 'Thousands of people are affected now and will be over the next 20 years and it all could have been prevented. It's so wrong.'

Source

Thursday, December 27, 2007

LegalView Blog Informs Readers of New Mesothelioma Cancer Treatment Center Being Built to Aid Mesothelioma Cancer Victims

LegalView.com offers readers several mesothelioma resources including its continually updated mesothelioma blog. A recent blog post regarding mesothelioma offered readers an inside into a new mesothelioma treatment center that is to be built in Australia.

Denver, CO (PRWEB) December 23, 2007 -- LegalView, the number one source for everything legal on the Internet, recently updated its mesothelioma legal blog to inform readers and sufferers of mesothelioma about a new mesothelioma treatment center that will be built. The new center is scheduled to be open in a year, but, according to news reports, the treatment center's first goal is to ensure that every mesothelioma cancer victim will be able to access treatments available at the center.

Mesothelioma is a deadly and rare form of cancer that is inevitably incurable at the moment. While research continues to lengthen a victim's life as well as to ease the pain the cancer causes, there is still no way to 100 percent treat the cancer. Mesothelioma is usually caused by exposure to asbestos fibers that are breathed into the lung and essentially crystallize causing the development of cancer cells on the lining of the lung. It is typical that mesothelioma occurs anywhere from 10 to 40 years after initial exposure to asbestos. Many are currently being diagnosed with the cancer because of years of negligence by companies who knowingly endangered employees by exposing them to the deadly dust. If you or anyone you know has developed mesothelioma cancer, it may be in your best interest to contact a mesotehlioma law firm for more information.

The new mesothelioma treatment center is being built in honor of a local Sydney man who recently passed away. Bernie Benton was exposed to asbestos and began helping others dealing with the same plight. The mesothelioma treatment center will be one of the world's first asbestos research centers that focuses only on mesothelioma. Those suffering from mesothelioma cancer can find more information on this and other mesothelioma treatments at the mesothelioma information portal.

In addition to information regarding mesothelioma, LegalView.com also offers resources on several additional legal issues that are tragically affecting individuals throughout the country everyday. Readers will be able to find a traumatic brain injury law firm who specializes in helping brain injury victims with consultations and attorney referral services. Individuals who have suffered from a construction accident injury or an auto accident can find information on finding a construction accident attorney or auto accident lawyer through LegalView as well.


SOURCE

Thursday, December 13, 2007

PLEURAL MESOTHELIOMA PROGNOSIS

The prognosis of mesothelioma refers to the possible outcome of mesothelioma. Malignant pleural mesothelioma is a lethal disease and little is known about prognostic factors. A few have survived as long as 5 years, with rates of 14% for all types and 46% for the epithelial type. However, there are long term pleural mesothelioma survivors who have survived more than 10 years (although very rare).

In a recent mesothelioma study, doctors writing about the prognosis of pleural mesothelioma explained that long-term mesothelioma survivors do exist and their prognosis may be independent of the treatment or therapies used.

Age, stage of disease, gender and histological subtype are factors that are considered when prognosis of pleural mesothelioma is being carried on. With trimodality treatment, some patients have survived 16-19 months. However, numbers are small. Despite a ban on asbestos (major cause) use in Western countries, the incidence of malignant pleural mesothelioma is increasing, due to the long delay between asbestos exposure and diagnosis.

Moreover, asbestos is still used in developing countries.Without treatment, mesothelioma is fatal within 4-8 months.

Mesothelioma news; Adelaide mum defies odds surviving mesothelioma

The World Today - Thursday, 13 December
ELEANOR HALL: The asbestos disease, mesothelioma, is usually a death sentence, killing its victims within a year But an Adelaide mother has defied the medical odds by not only surviving the deadly asbestos-related disease mesothelioma but having a child 10 years after her diagnosis।39-year-old Belinda Dunn took part in a gene therapy trial soon after she received the news she had mesothelioma।But medical experts are still baffled by her survival, as Nance Haxton reports from Adelaide.

NANCE HAXTON: Belinda Dunn is a medical mystery. Her only contact with deadly asbestos dust was as a small child when she played on a pile of fibro while her parents were extending their house. The 39-year-old Adelaide mother of one was diagnosed with mesothelioma soon after the birth of her first child, Nathan, 10 years ago, and told she had little chance of living beyond a year. But a decade on, not only has she survived the disease, but she is pregnant as well.

BELINDA DUNN: It's a very daunting thought, actually. Where I was 10 years ago to where I am now.

NANCE HAXTON: Belinda Dunn took part in an experimental gene therapy trial in the United States soon after her diagnosis. But she says she doesn't credit her current good health exclusively to that treatment.

BELINDA DUNN: I've taken lots and lots of vitamins at the time of - under the guidance of my naturopath - with the gene therapy trial, and I'm just wondering if it was because my immune system was in good shape when I had the trial that perhaps that's helped it

NANCE HAXTON: And you've had no complications with the pregnancy from the mesothelioma so far?

BELINDA DUNN: Well, not from - not anything I've had normally for the last 10 years, because I suffer, still, like an arthritic type pain, like shoulder tip pain and I know when my mesothelioma is active, if you want to call it that, or it's my chest is inflamed and basically, I just live with that. And that's part of being pregnant and having mesothelioma.

NANCE HAXTON: Professor Doug Henderson from the Flinders Medical Centre in Adelaide was the doctor who initially diagnosed Belinda Dunn with mesothelioma. He says he never would have thought 10 years on from that day that he would be talking about her still being alive and well.

DOUG HENDERSON: I certainly didn't - it's a very unexpected but very positive and good outcome

NANCE HAXTON: But Professor Henderson says sadly, Belinda Dunn's recovery cannot be explained by science, and therefore has little significance at this stage for other sufferers.

DOUG HENDERSON: I have seen other rare cases of mesothelioma that have gone into apparently spontaneous complete remission and one patient whom I remember very vividly was alive with a completely normal chest X-ray and otherwise well, eight years after the diagnosis had been made.

NANCE HAXTON: What can this be put down to?

DOUG HENDERSON: We don't know the reasons for spontaneous regression like this in tumors. It might be due to some altered cellular dynamics within the tumor itself, but why that should happen we really have no clear idea. The other theory is that the immune system of a body somehow gains a boost and gains ascendancy over the tumor and puts it into remission.

NANCE HAXTON: So are there any ramifications from these rare cases that could be applied to other victims of this disease?

DOUG HENDERSON: I don't think so, these are the exceptions rather than the rule and I'm not sure that one could use these people or any factor from these people to treat other patients, because we don't know what the factors that are involved in this type of remission really are. I think only time will tell the eventual outcome but I hope that Belinda will have a virtually normal life expectancy, taking into account that she's now been in apparently complete remission with no evidence of progressive disease for some 10 years.


NANCE HAXTON: While Ms Dunn is grateful for her health, she struggles with losing many of the friends she has made through asbestos disease support groups, including Bernie Banton. She hopes that her case, while something of a miracle, gives hope to other people with mesothelioma - which it does not have to be a death sentence.

BELINDA DUNN: I really hope, you know, that that's what it's doing because, you know, if it's worked for me, surely someone will start thinking about what I had been doing with the vitamins when I had my trial and perhaps they can move on to do some research into what I was taking when I had the gene therapy, and perhaps someone else might be lucky and live with mesothelioma.
That's the mystery mesothelioma survivor, Belinda Dunn.

Wednesday, December 12, 2007

PLEURAL MESOTHELIOMA DIAGNOSIS

Presently there seems to be no cure for mesothelioma, but its early diagnosis can provide doctors the opportunity to relieve the patients of a great deal of suffering, and prolong their lives thus improving their general health outlook। These treatment options depend on the stage and the overall progession of the disease. The pleural form of mesothelioma, which represents more than 90% of all cases, presents on x-ray as diffuse unilateral or bilateral pleural thickening that appears to encase the lungs, usually producing blunting of the costophrenic angles. Pleural effusions are present in 95% of cases and are typically unilateral, massive effusions.





Diagnosis is majorly based on pleural fluid cytology or open pleural biopsy and, if these are nondiagnostic, biopsy by video-assisted thorascopic surgery (VATS) or thoracotomy is used.
Staging is done with chest CT, mediastinoscopy, and MRI. Sensitivity and specificity of MRI and CT are comparable, although MRI is helpful in determining tumor extension into the spine or spinal cord. PET may have better sensitivity and specificity for distinguishing benign from malignant pleural thickening.
Using Bronchoscopy rules out coexisting endobronchial malignancies। Increased hyaluronidase levels in pleural fluid are suggestive but not diagnostic of disease. Soluble mesothelin-related proteins released into the serum by mesothelial cells are being studied as possible tumor markers for disease detection and monitoring.


Mesothelioma स्टील remains an incurable cancer.

Tuesday, December 11, 2007

MESOTHELIOMA NEWS; Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed

In our quest to finding a lasting solution to mesothelioma, hope seems not to be lost.

Earlier this year Rosetta Genomics, Ltd. announced that it had partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung and mesothelioma cancers.
The early detection test will mainly target over 45 million Americans who are at an increased risk of lung cancer due to smoking, as well as those who have been exposed to asbestos fibers. The test will utilize Rosetta Genomics' proprietary protocol to extract microRNAs from a simple blood draw.

"A test that will be able to detect cancer at an early stage using a simple blood draw will have far reaching implications on the fight against cancer," noted Dr. Harvey Pass, Professor and Chief, Division of Thoracic Surgery and Thoracic Oncology at NYU Medical Center.

"MicroRNAs have been shown to hold great potential as effective biomarkers for various cancers, and I believe that NYU Medical Center's vast experience with lung cancer and Mesothelioma, coupled with Rosetta Genomics' expertise in the microRNA field, will allow us to successfully advance this much needed test forward."

This new development will help in future diagnoses and for lasting treatment for the rare deadly disease. Other firms are also developing new treatment options, but for now, I think one has to avoid asbestos as possible as one can, to prevent contacting this disease.

Monday, December 10, 2007

SYMPTOMS OF PLEURAL MESOTHELIOMA

Pleural mesothelioma is a disease whose symptoms are not easily noticeable. Although at the early stages of the disease patients do complain of recurring heart and chest pains.



Generally the symptoms are always mild at the initial stages but do get serious and complicated as soon as it reaches its matured that is when it becomes visible. Chest pain is the most common. Other symptoms include; coughs, weight loss and anorexia. Others are persistent coughing, difficulty in swallowing, facial swelling, weight loss, fever, rasping, and coughing up blood.



In some cases patients do complain of shortness of breath. This is as a result of the thickening of the pleura as the tumour begins to spread. This makes it to be filled with fluid. This fluid leads to the discomfort or pain associated with first detection of the disease.



Pleural mesothelioma patients display all three types of mesothelioma cancer cells: epithelioid mesothelioma, sarcomatoid mesothelioma and biphasic mesothelioma

PLEURAL MESOTHELIOMA

When the famous Australian anti-racism activist Bob Bellear died in 2005 of mesothelioma, not until then did the disease started becoming popular. Mesothelioma occurs in different forms of which pleural mesothelioma is one.

Pleura mesothelioma is a form of mesothelioma that occurs around the lungs and respiratory area of the chest region. It attacks the cell and the linings of the lungs which are known as the pleura, hence the name pleura.





It do start from the lungs and in some cases spread to other parts of the body including the brain thereby causing more damage than not





Sometimes it occur in two forms- benign (non-cancerous) and malignant (cancerous) but malignant is the most common of the two.
It is the most common form of mestheolima, 7-8 out of every 10 cases of mesothelioma cases are mesothelioma of the pleura. Due to the nature of this disease it might take 30-50years before the symptoms start to surface after being exposed to asbestos. This makes the disease not to be known until when it is too late.

Saturday, December 8, 2007

MESOTHELIOMA DIAGNOSIS

The diagnosis of mesothelioma is not always an easy task for doctors and researchers. This is due to the numerous symptoms of mesothelioma which are evidences of the presence of other diseases and the latency between the period of contraption and showing of symptoms.

Hence it is always important to check the medical file of a patient when diagnosing. In most cases mesothelioma is usually in its matured stage which makes it a little bit hard for much to be known. A diagnosis of mesothelioma is obtained firstly, through the assessment of the patient’s medical file, a CT scan (computerized technology) or CAT (computerized axial tomography), MRI (magnetic resonance imaging) and a biopsy. The CT helps to take internal pictures of the internal organs of the body while the MRI allows getting perfect detailed images of the inner body are through a powerful magnet linked to computer.

The scans are followed by a biopsy which is used to confirm the presence of mesothelioma. To perform biopsy, a close examination is made on the fluids surrounding the lungs, when present, by an oncologist. This might not be sufficient, so, a small cut might be made to remove a tissue from the patient with a hollow needle which is inserted into the patient's chest cavity to run biopsy on. This process is known as thorascopy. This is altogether known as open pleural biopsy. The process is known as peritoneoscopy if the tissues are taken from the abdominal cavity.

The disease is declared localized if the cancer is found on the surface of the membrane, but it will be advanced if it has spread to other parts of the body. The early detection of mesothelioma depends on the patients’ awareness of its presence. Diagnosis of mesothelioma is always poor due to the fact that it is rare, the non-specific nature of its symptoms, and the time lag between asbestos exposure and a patient’s symptomatic response, could take 50 years. Despite all this frictions, there are many available procedures or the diagnoses of mesothelioma.


MESOTHELIOMA PROGNOSIS

The prognosis of mesothelioma refers to the possible outcome of mesothelioma. Mesothelioma prognosis and treatment options is determined by the size of of the tumour, the stage of the tumour, the duration of the mesothelioma tumour, the type of the mesothelioma tumour, the overall health and age of the patient, the level of exposure to asbestos and whether cancerous cells could be located in other parts of the body. Chances of recovery, recovery period for mesotholima, the survival rate of mesothelioma, the death rate and all possible outcomes are also entailed in the prognosis of mesothelioma.


Diagnosis is then conducted through physical examination and results which confirms a full mesthelioma prognosis. After this, treatments options are now considered to determine the best treatment option.
Due to the incurability of mesothelioma treatment options are designed to relieve symptoms, prevent metastasis and prolong life expectancy. Diagnosis plays a vital role in mesothelioma prognosis. The earlier the diagnosis, the earlier the better as it becomes worse the longer the cancer is left unknown as there might be no curative treatment. But in most cases, mesothelioma is usually diagnosed in its matured stage, this makes mesothelioma to be a little bit hard to understand, thus the seven percent in five years survival rate. Yet, sufferers do have a reason to hope.


Scientists are already developing new methods and the FDA now allows the pharmaceutical industry to try new compounds o mesothelioma patients which may make the survival rate to be high next year. It is advisable for one when he/she is diagnosed of mesothelioma to contact a doctor for proper care and help.


Thursday, December 6, 2007

TYPES OR FORMS OF MESOTHELIOMA CANCER

The type of mesothelioma is determined on the basis where the cancer occurs in the body. Mesothelioma may affect any part or organ of the body depending on the level of exposure to asbestos and the time level over which the patient has been exposed to.
The major types of mesthelioma cancer includes the following;

* Pleural Mesothelioma

*Peritoneal Mesothelioma

* Pericardial Mesothelioma

Pleural Mesothelioma

Pleural mesothelioma, also known as mesothelioma of the pleura is a tumour in which the lining of the lungs, or lung pleura, gets affected by malignant cells. It is one of the most commonly occurring cancers. The pleura is a thin tissue around the lungs and the inside of the chest.
It helps the lungs in breathing (respiration) by producing a serous fluid that lubricates the pleural surfaces to avoid the teasing of the lungs against the chest wall. In order to protect the lungs, the pleura produces a small amount of fluid which helps cushion the lungs, making the lungs move more smoothly during breathing.

Types of pleural mesothelioma cancer

Diffused or Malignant (Cancerous) MESOTHELIOMA

Malignant Pleural mesothelioma is cancerous and can spread to other parts of the body. This rare form of cancer is found in the pleural sac lining of the lung. Exposure to asbestos is considered the primary cause of pleural mesothelioma.

Benign (Non-Cancerous) pleural mesothelioma

This is the non-cancerous form of pleural mesothelioma, which does not affect all parts of the body but the pleura. However, it constricts the lung causing shortness of breath, and in some severe cases, pneumothorax (lung failure)

Peritoneal mesothelioma

This is the next common type of mesothelioma which affects peritonium which is the lining of the abdominal cavity including the stomach. It is more aggressive than the mesothelioma of the pleura. Its symptoms include the following chest pain, anaemia, breathlessness, loss of appetite and other severe symptoms. It could either be malignant (cancerous) or benign (non-cancerous). Their is a high probability of women being diagnosed with peritoneal mesothelioma than other types of mesothelioma.

Pericardial mesothelioma

This is the rarest and least but deadliest type of mesothelioma because it affects the heart and the cavity surrounding it. It is said to have an average lifespan of less than six months from diagnosis. Due to the rarity of this disease as many patients are ignorant of the presence of this disease in their body until diagnosis is made on their autopsies, it makes it difficult for doctors and researchers to understand the whole logic behind the nature of this disease.

Symptoms might include congestive heart failure, palpitation, night sweat, persistent cough, chest pain and breathing disorder. Pericardial mesothelioma can sometimes be palpatively treated through surgery and further treatment of radiation and chemotherapy.

Every year about 2,000 new cases of mesothelioma are being diagnosed, and the figure might still be increasing. The major cause of mesothelioma has been linked to asbestos inhaling due to being exposed to it. So watch out next time you are out in mining area.

Wednesday, December 5, 2007

Other treaments for malignant mesothelioma

There are other different types of treatment for patients with malignant mesothelioma.


Different types of treatments are available for patients with malignant mesothelioma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. Before starting treatment, patients may want to think about taking part in a clinical trial. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.


Clinical trials are taking place in many parts of the country. Information about ongoing clinical trials is available from the NCI Web site. Choosing the most appropriate cancer treatment is a decision that ideally involves the patient, family, and health care team.
Three types of standard treatment are used:

Surgery


The following surgical treatments may be used for malignant mesothelioma:


Wide local excision: Surgery to remove the cancer and some of the healthy tissue around it.


Pleurectomy and decortication: Surgery to remove part of the covering of the lungs and lining of the chest and part of the outside surface of the lungs.


Extrapleural pneumonectomy: Surgery to remove one whole lung and part of the lining of the chest, the diaphragm, and the lining of the sac around the heart.


Pleurodesis: A surgical procedure that uses chemicals or drugs to make a scar in the space between the layers of the pleura. Fluid is first drained from the space using a catheter or chest tube and the chemical or drug is put into the space. The scarring stops the build-up of fluid in the pleural cavity. Even if the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given chemotherapy or radiation therapy after surgery to kill any cancer cells that are left. Treatment given after surgery, to increase the chances of a cure, is called adjuvant therapy.

Radiation therapy


Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation toward the cancer. Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. The way the radiation therapy is given depends on the type and stage of the cancer being treated.

Chemotherapy


Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the spinal column, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). Combination chemotherapy is the use of more than one anticancer drug. The way the chemotherapy is given depends on the type and stage of the cancer being treated.


New types of treatment that are being tested in clinical trials include the following:

Biologic therapy


Biologic therapy is a treatment that uses the patient’s immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body’s natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.

Saturday, December 1, 2007

TREATMENTS FOR MALIGNANT MESOTHELIOMA



TREATMENTS OF MALIGNANT MESOTHELIOMA

Physical exam and history
: An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patient’s health habits, exposure to asbestos, past illnesses and treatments will also be taken.
Chest x-ray: An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.
Complete blood count (CBC): A procedure in which a sample of blood is drawn and checked for the following:
The number of red blood cells, white blood cells, and platelets.
The amount of hemoglobin (the protein that carries oxygen) in the red blood cells.
The portion of the blood sample made up of red blood cells.
Sedimentation rate: A procedure in which a sample of blood is drawn and checked for the rate at which the red blood cells settle to the bottom of the test tube.
Biopsy: The removal of cells or tissues from the pleura or peritoneum so they can be viewed under a microscope by a pathologist to check for signs of cancer. Procedures used to collect the cells or tissues include the following:
Fine-needle aspiration biopsy: The removal of part of a lump, suspicious tissue, or fluid, using a thin needle. This procedure is also called a needle biopsy.
Lung biopsy. The patient lies on a table that slides through the computed tomography (CT) machine which takes x-ray pictures of the inside of the body. The x-ray pictures help the doctor see where the abnormal tissue is in the lung. A biopsy needle is inserted through the chest wall and into the area of abnormal lung tissue. A small piece of tissue is removed through the needle and checked under the microscope for signs of cancer.

Thoracoscopy: An incision (cut) is made between two ribs and a thoracoscope (a thin, lighted tube) is inserted into the chest.
Peritoneoscopy: An incision (cut) is made in the abdominal wall and a peritoneoscope (a thin, lighted tube) is inserted into the abdomen.
Laparotomy: An incision (cut) is made in the wall of the abdomen to check the inside of the abdomen for signs of disease.
Thoracotomy: An incision (cut) is made between two ribs to check inside the chest for signs of disease.
Bronchoscopy: A procedure to look inside the trachea and large airways in the lung for abnormal areas. A bronchoscope (a thin, lighted tube) is inserted through the nose or mouth into the trachea and lungs. Tissue samples may be taken for biopsy.
Bronchoscopy. A bronchoscope is inserted through the mouth, trachea, and major bronchi into the lung, to look for abnormal areas. A bronchoscope is a thin, tube-like instrument with a light and a lens for viewing. It may also have a cutting tool. Tissue samples may be taken to be checked under a microscope for signs of disease.
Cytologic exam: An exam of cells under a microscope (by a pathologist) to check for anything abnormal. For mesothelioma, fluid is taken from around the lungs or from the abdomen. A pathologist checks the cells in the fluid.
Certain factors affect prognosis (chance of recovery) and treatment options.
The prognosis (chance of recovery) and treatment options depend on the following:
The stage of the cancer.

The size of the tumor.

Whether the tumor can be removed completely by surgery.

The amount of fluid in the chest or abdomen.

The patient's age and general health, including lung and heart health.

The type of mesothelioma cancer cells and how they look under a microscope.
Whether the cancer has just been diagnosed or has recurred (come back).

Stages of Malignant Mesothelioma

After malignant mesothelioma has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body. The stages of malignant mesothelioma are divided into two groups.

Localized malignant mesothelioma (stage I) Advanced malignant mesothelioma (stage II, stage III, and stage IV)

After malignant mesothelioma has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body. The process used to find out if cancer has spread outside the pleura or peritoneum is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the spread of the cancer in order to plan treatment.

The following tests and procedures may be used in the staging process:


Chest x-ray: An x-ray of the organs and bones inside the chest. An x-ray is a type of energy beam that can go through the body and onto film, making a picture of areas inside the body.

CT scan (CAT scan): A procedure that makes a series of detailed pictures of the chest and abdomen, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.

MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of the chest or abdomen. This procedure is also called nuclear magnetic resonance imaging (NMRI). The stages of malignant mesothelioma are divided into two groups.

Malignant mesothelioma stages are grouped into localized and advanced.

Localized malignant mesothelioma (stage I)

In localized malignant mesothelioma, cancer is found in the lining of the chest wall and may also be found in the lining of the lung, the lining of the diaphragm, or the lining of the sac that covers the heart on the same side of the chest.

Advanced malignant mesothelioma (stage II, stage III, and stage IV)

Advanced malignant mesothelioma includes stage II, stage III, and stage IV.

In stage II, cancer is found in the lining of the chest wall and the lymph nodes on the same side of the chest. Cancer may also be found in the lining of the lung, the lining of the diaphragm, or the lining of the sac that covers the heart on the same side of the chest.

In stage III, cancer has spread to any of the following areas: The chest wall. The mediastinum. The heart. Beyond the diaphragm. The peritoneum.

Cancer may have also spread to lymph nodes on the other side of the chest or outside the chest. In stage IV, cancer has spread to distant organs or tissues.

Recurrent Malignant Mesothelioma

Recurrent malignant mesothelioma is cancer that has recurred (come back) after it has been treated. The cancer may come back in the chest or abdomen or in other parts of the body.

LinkWithin